Significantly higher scores of positive SRGN (Figure 5e) and TGFβ2 (Figure 5f) staining was observed in breast cancer tumors with lymph node metastases (Nodal Positive) compared with breast cancer tumors without lymph node metastases (Nodal Free) (P<0.01). This evidence concerns the gene TGFB2 and breast cancer.